Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT06647394

Efficacy of Application of Myriad Matrix to Split Thickness Skin Graft Sites

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
University of Alabama at Birmingham · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To determine if application of Myriad Matrix to split thickness skin graft donor sites improves post-operative pain and appearance of the wound.

Detailed description

In the head and neck practice at UAB, split thickness skin grafts are a commonly used procedure for simple reconstruction. The standard dressing for donor sites is a strip of vaseline gauze which remains on the site the wound dries, and the gauze eventually falls off. Post operative pain and poor wound healing is a well established complication of the donor site, and various methods have been studied in an attempt to reduce these complications for patients in the post operative period. (1, 2, 3) Myriad matrix is an engineered extracellular matrix (Ovine Forestomach Matrix) used for soft issue repair in complex wounds. This has been sporadically used by some of the faculty members at UAB for split thickness skin graft donor site dressings with anectodal improvement in pain and healing, though this has not yet been studied to our knowledge.

Conditions

Interventions

TypeNameDescription
PROCEDUREMatrix Dressingextracellular matrix dressing soaked in 4% topical lidocaine to the skin graft donor site

Timeline

Start date
2025-03-01
Primary completion
2026-12-01
Completion
2028-02-01
First posted
2024-10-17
Last updated
2025-05-25

Source: ClinicalTrials.gov record NCT06647394. Inclusion in this directory is not an endorsement.